The Effect of Streptococcal Pyrogenic Exotoxin Type A (SpeA) on the Formation of Streptococcus pyogenes Biofilm

Area of Science:

• Microbiology
• Bacterial Pathogenesis
• Molecular Biology

Background:

• Streptococcus pyogenes forms biofilms, contributing to persistent infections.
• Bacterial biofilms protect against host defenses and antimicrobial agents.
• Streptococcal exotoxin A (SpeA) is a known superantigen.

Purpose of the Study:

• To investigate the effect of recombinant SpeA (rSpeA) on Streptococcus pyogenes biofilm formation.
• To determine if rSpeA can disrupt pre-formed S. pyogenes biofilms.
• To assess the potential of SpeA as a therapeutic agent against S. pyogenes biofilms.

Main Methods:

• Laboratory strains and clinical isolates of S. pyogenes were used.
• Biofilm formation assays were conducted in the presence of rSpeA.
• Established biofilms were treated with rSpeA to evaluate disruption.
• Bacterial growth inhibition was quantified using spectrophotometric methods.

Main Results:

• rSpeA inhibited the initial formation of S. pyogenes biofilms in a strain-dependent manner.
• Significant growth inhibition was observed for strain M30 (1.6-fold) and clinical strains 1, 2, and 3 (2.3-, 1.3-, and 1.4-fold, respectively).
• rSpeA demonstrated a more pronounced inhibitory effect on established biofilms, with significant disruption observed for strain M30 (2.5-fold) and strains 2, 3, and 5 (5.5-, 3.4-, and 4.2-fold, respectively).
• Inhibition was minimal for strains 4 and 5 during initial biofilm formation.

Conclusions:

• Recombinant SpeA possesses dual activity against S. pyogenes biofilms, inhibiting formation and disrupting established structures.
• SpeA's superantigen properties extend to biofilm destruction, suggesting a role in limiting bacterial dissemination.
• These findings highlight SpeA as a potential therapeutic target for managing S. pyogenes infections by combating biofilm formation.